Neurocrine Biosciences Inc. Share Price Today: Live Updates & Key Insights
Neurocrine Biosciences Inc. share price today is $127.68, up -1.56%. The stock opened at $129.81 against the previous close of $129.7, with an intraday high of $129.81 and low of $126.77.
Neurocrine Biosciences Inc. Share Price Chart
Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc. Share Price Performance
Neurocrine Biosciences Inc. Institutional Holdings
Neurocrine Biosciences Inc. Market Status
Neurocrine Biosciences Inc. Fundamentals
Market Cap 12814.41 M
PB Ratio 4.0015
PE Ratio 27.7565
Enterprise Value 11952.04 M
Total Assets 4631.50 M
Volume 2182008
Neurocrine Biosciences Inc. Company Financials
About Neurocrine Biosciences Inc. & investment objective
Company Information Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia, as well as offers products under the name of ALKINDI and Efmody. Its product candidates in clinical development includes NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia and bipolar mania; NBI-1117567 for the treatment of Alzheimer's disease; NBI 921355 for the treatment of epilepsy; NBIP-01435 for the treatment of congenital adrenal hyperplasia; NBIP-2118 for the treatment of obesity and related metabolic diseases; and NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, NBI-1140675, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Sanofi S.A.; Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.
Organisation Drug Manufacturers - Specialty & Generic
Employees 2000
Industry Drug Manufacturers - Specialty & Generic
CEO Mr. Kyle W. Gano Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Neurocrine Biosciences Inc. FAQs
What is the share price of Neurocrine Biosciences Inc. today?
The current share price of Neurocrine Biosciences Inc. is $127.68.
Can I buy Neurocrine Biosciences Inc. shares in India?
Yes, Indian investors can buy Neurocrine Biosciences Inc. shares by opening an international trading and demat account with Motilal Oswal.
How to buy Neurocrine Biosciences Inc. shares in India?
You can easily invest in Neurocrine Biosciences Inc. shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Neurocrine Biosciences Inc. shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Neurocrine Biosciences Inc..
Can I buy fractional shares of Neurocrine Biosciences Inc.?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Neurocrine Biosciences Inc.?
Neurocrine Biosciences Inc. has a market cap of $12814.41 M.
In which sector does Neurocrine Biosciences Inc. belong?
Neurocrine Biosciences Inc. operates in the Drug Manufacturers - Specialty & Generic sector.
What documents are required to invest in Neurocrine Biosciences Inc. stocks?
To invest, you typically need:
What is the PE and PB ratio of Neurocrine Biosciences Inc.?
The PE ratio of Neurocrine Biosciences Inc. is 27.76 and the PB ratio is 4.00.